News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VirtualScopics, LLC Schedules Second Quarter 2013 Earnings Announcement


7/30/2013 6:12:59 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

ROCHESTER, N.Y., July 29, 2013 /PRNewswire/ -- VirtualScopics, Inc. (NASDAQ: VSCP), a leading provider of quantitative imaging, today announced that before the market opens on Tuesday, August 13, 2013 it will release its second quarter 2013 financial results. VirtualScopics' management will provide a business update and discuss the company's results for the quarter ended June 30, 2013 at its Annual Stockholders' Meeting to be held later that day at 11:00 am ET at The Country Club of Rochester in Rochester, New York.

The script of the meeting can be accessed through the U.S. Securities and Exchange Commission's website, www.sec.gov. at the conclusion of the meeting.

About VirtualScopics, Inc.
VirtualScopics, Inc. is a leading provider of imaging solutions to accelerate drug and medical device development. VirtualScopics has developed a robust software platform for analysis and modeling of both structural and functional medical images. In combination with VirtualScopics' industry-leading experience and expertise in advanced imaging biomarker measurement, this platform provides a uniquely clear window into the biological activity of drugs and devices in clinical trial patients, allowing sponsors to make better decisions faster. For more information about VirtualScopics, visit www.virtualscopics.com.

Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. These forward-looking statements include, but are not limited to, statements regarding the backlog and new customer awards and/or statements preceded by, followed by or that include the words "believes," "could," "expects," "anticipates," "estimates," "intends," "plans," "projects," "seeks," or similar expressions. Forward-looking statements deal with the Company's current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Many of these risks and uncertainties are discussed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed with the Securities and Exchange Commission (the "SEC"), and in any subsequent reports filed with the SEC, all of which are available at the SEC's website at www.sec.gov. These include without limitation: the risk of cancellation or delay of customer contracts or specifically as it relates to awards of contracts currently under negotiation, the risk that they may not get signed. Other risks include the company's dependence on its largest customers and risks of contract performance. All forward-looking statements speak only as of the date of this press release and the Company undertakes no obligation to update such forward-looking statements.

CONTACTS:

Investor Relations:

Company Contact:


Tim Ryan

Molly Henderson


The Shoreham Group

Chief Business and Financial Officer, Sr. Vice President


80 Eighth Ave, Ste 1107

500 Linden Oaks


New York, NY 10011

Rochester, New York 14625


+1 212 242 7777 Direct

+1 585 249.6231


tryan@shorehamgroupllc.com


SOURCE VirtualScopics, Inc.



Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES